{"title":"Corrigendum to Cervical cerclage for short cervix at 24 to 26 weeks of gestation: systematic review and meta-analysis of randomized controlled trials using individual patient-level data American Journal of Obstetrics & Gynecology MFM Volume 5, Issue 6, June 2023, 100930","authors":"Moti Gulersen MD, MSc , Erez Lenchner PhD , Kypros H. Nicolaides MD , Katsufumi Otsuki MD , Orion A. Rust MD , Sietske Althuisius MD , Eran Bornstein MD , Vincenzo Berghella MD","doi":"10.1016/j.ajogmf.2024.101411","DOIUrl":"10.1016/j.ajogmf.2024.101411","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"7 8","pages":"Article 101411"},"PeriodicalIF":3.8,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144567946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"ACUPUNT study: addressing concerns on trial design and traditional Chinese medicine protocols","authors":"Montserrat Zamora-Brito BSc , Federico Migliorelli PhD , Montse Palacio PhD","doi":"10.1016/j.ajogmf.2025.101734","DOIUrl":"10.1016/j.ajogmf.2025.101734","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"7 9","pages":"Article 101734"},"PeriodicalIF":3.1,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144565286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Julia Whitley MD , Julia Burd MD , Michelle Doering MLIS , Amanda Zofkie MD , Antonina Frolova MD, PHD , Jeannie Kelly MD, MS , Nandini Raghuraman MD, MSCI
{"title":"Postpartum diuretic administration and hospital readmission: a systematic review and meta-analysis","authors":"Julia Whitley MD , Julia Burd MD , Michelle Doering MLIS , Amanda Zofkie MD , Antonina Frolova MD, PHD , Jeannie Kelly MD, MS , Nandini Raghuraman MD, MSCI","doi":"10.1016/j.ajogmf.2025.101738","DOIUrl":"10.1016/j.ajogmf.2025.101738","url":null,"abstract":"<div><h3>Objective</h3><div>We aimed to determine if postpartum administration of loop diuretic therapy among patients at risk of or diagnosed with a hypertensive disorder of pregnancy impacts the rate of hospital readmission compared to typical care.</div></div><div><h3>Data sources</h3><div>This study was a systematic review and meta-analysis of randomized controlled trials (RCTs). A research librarian performed a database search using a combination of standardized terms and keywords related to postpartum hypertension and loop diuretics from database inception until February 2025. This study was registered in PROSPERO (registration number CRD42024546708).</div></div><div><h3>Study eligibility criteria</h3><div>RCTs that compared outcomes between administration of loop diuretic therapy and routine care among postpartum patients at risk of or diagnosed with a hypertensive disorder of pregnancy were included. Inclusion criteria and diagnosis of hypertensive disorder of pregnancy were defined per each trial’s protocol. Nonrandomized trials, quasi-randomized trials, and animal models were excluded. All titles and abstracts obtained through the search were independently assessed by two reviewers using the screening tool in Covidence, and full-text articles were reviewed. A total of 10 articles met inclusion criteria and were included in the systematic review and meta-analysis.</div></div><div><h3>Study appraisal and synthesis methods</h3><div>Two independent investigators independently abstracted data using a standardized template created in Covidence. The primary outcome was the rate of hospital readmission. Secondary maternal outcomes included readmission for hypertension, mean postpartum blood pressure, and severe maternal morbidity. The risk of bias in each study was assessed using the guidelines outlined in the Cochrane Handbook for Systematic Reviews of Interventions. Heterogeneity was measured using Higgins <em>I</em><sup>2</sup>. Meta-analysis was performed in Review Manager 5.4.1 to produce summary treatment effects in terms of relative risk (RR) or mean difference with 95% confidence intervals (CIs).</div></div><div><h3>Results</h3><div>Ten RCTs, including 1401 patients, were included in the meta-analysis. The rate of hospital readmission, reported in 3 studies, did not differ between administration of loop diuretic therapy and routine care (RR=2.00; 95% CI, 0.71–5.67). The rate of readmission for hypertension also did not differ between groups (3 studies, RR=0.69; 95% CI, 0.35–1.36). Additional antihypertensive requirements were lower in patients who received diuretics (6 studies, RR=0.47; 95% CI, 0.26–0.85). There were no differences in any other secondary maternal outcomes, including discharge on antihypertensives (8 studies, RR=1.00; 95% CI, 0.91–1.11), hospital length of stay (6 studies, mean difference=0.15; 95% CI, –0.18 to 0.48), or severe maternal morbidity.</div></div><div><h3>Conclusion</h3><div>There is insufficient evidence to ","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"7 9","pages":"Article 101738"},"PeriodicalIF":3.8,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144565329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Katherine Pressman MD, Rebecca Nunge MD, Madeline Erwich BS, Gustavo Vilchez Lagos MD, PhD, Anthony O. Odibo MD MSCE, Jose R. Duncan MD
{"title":"Comparison of fetal abdominal circumference references for the prediction of small for gestational age","authors":"Katherine Pressman MD, Rebecca Nunge MD, Madeline Erwich BS, Gustavo Vilchez Lagos MD, PhD, Anthony O. Odibo MD MSCE, Jose R. Duncan MD","doi":"10.1016/j.ajogmf.2025.101737","DOIUrl":"10.1016/j.ajogmf.2025.101737","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"7 9","pages":"Article 101737"},"PeriodicalIF":3.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144561405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effectiveness of self-care interventions for the prevention of type 2 diabetes among women with previous gestational diabetes: a systematic review and meta-analysis","authors":"Sho Katsuragawa MD, MPH , Thuy Mai MPH , Annie R.A. McDougall PhD , Lorena Romero MBIT , Joshua P. Vogel PhD , Maureen Makama PhD","doi":"10.1016/j.ajogmf.2025.101731","DOIUrl":"10.1016/j.ajogmf.2025.101731","url":null,"abstract":"<div><h3>Objective</h3><div>Gestational diabetes (GDM) is associated with an increased risk of developing type 2 diabetes later in life. Self-care interventions are known to prevent type 2 diabetes in high-risk populations. This systematic review aimed to investigate whether self-care interventions can prevent type 2 diabetes among women with previous GDM.</div></div><div><h3>Data sources</h3><div>A systematic search of MEDLINE, Embase, Cochrane Library, CINAHL, and PsycINFO was conducted on December 2, 2024.</div></div><div><h3>Study eligibility criteria</h3><div>Randomised, cluster-randomised, and non-randomised controlled trials that compared the effects of self-care interventions with standard/usual care or no intervention for preventing type 2 diabetes among women with previous GDM were included. The primary outcomes were the incidence of type 2 diabetes, the composite incidence of any type of diabetes, glycated hemoglobin, fasting blood glucose, blood glucose level 2 hours after the oral glucose tolerance test, and body weight.</div></div><div><h3>Study appraisal and synthesis methods</h3><div>Risk of bias for included studies was assessed using the Cochrane risk-of-bias tool (ROB2) or the Risk of Bias In Non-Randomized Studies of Interventions tool (ROBINS-I). Random effects models were employed for meta-analyses. The certainty of evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation approach.</div></div><div><h3>Results</h3><div>The search identified 35 trials including 6624 women. Only one randomised trial (<em>n</em>=1601) reported the incidence of type 2 diabetes, indicating that the lifestyle intervention focusing on diet and physical activity may have little to no effect (hazard ratio 0.89 [95% confidence interval 0.65–1.22], low certainty of evidence). The effects of self-care interventions on the other primary outcomes—composite incidence of any type of diabetes (three trials), glycated hemoglobin (three trials), fasting blood glucose (11 trials), blood glucose level 2 hours after the oral glucose tolerance test (six trials), and body weight (18 trials) were uncertain (very low certainty of evidence). Downgrading of the certainty of evidence was predominantly due to high risk of bias, imprecision, and inconsistency.</div></div><div><h3>Conclusion</h3><div>Available evidence on the effect of self-care interventions for the prevention of type 2 diabetes among women with previous GDM is insufficient to draw strong conclusions, necessitating further research.</div></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"7 9","pages":"Article 101731"},"PeriodicalIF":3.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144561406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Letter to editor regarding Acupuncture before planned admission for induction of labor (ACUPUNT study): a randomized controlled trial","authors":"Han Zhang PhD, Yang Yu MD, Yi-Jie Hu MD","doi":"10.1016/j.ajogmf.2025.101733","DOIUrl":"10.1016/j.ajogmf.2025.101733","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"7 9","pages":"Article 101733"},"PeriodicalIF":3.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144561407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Response to Letter to the Editor: standardized cardiovascular risk assessment in pregnancy and postpartum","authors":"Afshan B. Hameed MD, MBA, FACOG, FACC, Maryam Tarsa MD, MAS, Ashten Waks MD, MSPH","doi":"10.1016/j.ajogmf.2025.101736","DOIUrl":"10.1016/j.ajogmf.2025.101736","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"7 9","pages":"Article 101736"},"PeriodicalIF":3.1,"publicationDate":"2025-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144530055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The argument for normalizing nonsevere pregnancy hypertension : let us not repeat the CHIPS to CHAP delay","authors":"Laura A. Magee MD, Peter von Dadelszen DPhil","doi":"10.1016/j.ajogmf.2025.101702","DOIUrl":"10.1016/j.ajogmf.2025.101702","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"7 9","pages":"Article 101702"},"PeriodicalIF":3.1,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144530054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Caroline Fryar MD, MPH , Tingting Liu BS , Neill Bates MPH , Dmitry Tumin PhD , Kelly Bear DO , Rachel Taylor MD , James L. Whiteside MD
{"title":"Antenatal corticosteroid administration among infants born at 22 weeks’ gestation after a practice advisory endorsing its consideration","authors":"Caroline Fryar MD, MPH , Tingting Liu BS , Neill Bates MPH , Dmitry Tumin PhD , Kelly Bear DO , Rachel Taylor MD , James L. Whiteside MD","doi":"10.1016/j.ajogmf.2025.101728","DOIUrl":"10.1016/j.ajogmf.2025.101728","url":null,"abstract":"<div><h3>BACKGROUND</h3><div>In response to an accumulation of evidence supporting antenatal steroid administration at 22 weeks of gestation with planned neonatal resuscitation, the American College of Obstetricians and Gynecologists, alongside the Society for Maternal-Fetal Medicine, published a clinical practice advisory recommending consideration of antenatal steroids at 22 weeks of gestation in September 2021.</div></div><div><h3>OBJECTIVE</h3><div>This study aimed to determine whether the 2021 American College of Obstetricians and Gynecologists practice advisory was associated with an increase in the use of antenatal corticosteroids among infants born at 22 weeks of gestation.</div></div><div><h3>STUDY DESIGN</h3><div>This retrospective, secondary analysis used data from the United States Centers for Disease Control and Prevention’s National Vital Statistics System from 2017 to 2023. The primary outcome was antenatal steroid use as recorded on the birth certificate, and our main exposure was the birth year that was dichotomized as after (2022–2023) vs before (2017–2020) practice guideline implementation. The chi-square and rank-sum tests were used to compare gestational age before and after the implementation of the guideline, respectively. A multivariate regression using a difference-in-difference specification model was used to determine antenatal steroid use among births at 22 and 24 to 25 weeks of gestation, and a separate multivariate model was included using live births at 23 weeks of gestation for sensitivity analysis.</div></div><div><h3>RESULTS</h3><div>After applying our exclusion criteria, a total of 11,203 live births in the United States at 22 to 25 weeks of gestation between 2017–2020 and 2022–2023 were available for analysis. Our bivariate analysis indicated an increased use of antenatal steroids in live births at 22 weeks of gestation from 48% (178/368) before to 61% (216/356) after the American College of Obstetricians and Gynecologists guideline implementation (<em>P</em>=.001). However, steroid administration did not change at 23 weeks of gestation (<em>P</em>=.385), with only a slight increase from 63% to 66% at 24 to 25 weeks of gestation (<em>P</em>=.033) in our bivariate analysis. Our multivariate analysis found similar patterns, with 65% higher odds of steroid use in births at 22 weeks of gestation (<em>P</em>=.001), with no significant change in births at 24 to 25 weeks of gestation (<em>P</em>=.061). Similar results were found in our sensitivity analysis of births at 22 weeks of gestation (<em>P</em>=.001), but no significant association was identified for births at 23 weeks of gestation (<em>P</em>=.710).</div></div><div><h3>CONCLUSION</h3><div>The recommendation by the American College of Obstetricians and Gynecologists to consider antenatal corticosteroid administration in preterm deliveries at 22 weeks of gestation has led to an increase in this clinical practice. This significant association highlights the valu","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"7 9","pages":"Article 101728"},"PeriodicalIF":3.8,"publicationDate":"2025-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144486347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}